Close

Immune Pharma (IMNP) Files Patent Application for Ceplene/Checkpoint Inhibitors Combo

February 10, 2016 9:42 AM EST Send to a Friend
Immune Pharmaceuticals Inc. (NASDAQ: IMNP), "Immune", a clinical-stage biopharmaceutical company, announced today that it has filed a patent application directed ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login